一般外科
止血の管理と最適化
日本語
止血の管理と最適化
https://assetsnffrgf-a.akamaihd.net/assets/ct/d71826a198/images/syn_placeholder_sqr.png

一般外科

止血の管理と最適化

抗線溶薬

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (新しいタブで開く)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

出典‎: Cochrane Database Syst Rev 2011;(3):CD001886.

インデックス‎: PubMed 21412876

DOI‎: 10.1002/14651858.CD001886.pub4

https://www.ncbi.nlm.nih.gov/pubmed/21412876 (新しいタブで開く)

Safety and efficacy of tranexamic acid in general surgery. (新しいタブで開く)

Park LJ, Marcucci M, Ofori SN, Borges FK, Nenshi R, Kanstrup CTB, Rosen M, Landoni G, Lomivorotov V, Painter TW, Xavier D, Martinez-Zapata MJ, Szczeklik W, Meyhoff CS, Chan MTV, Simunovic M, Bogach J, Serrano PE, Balasubramanian K, Cadeddu M, Yang I, Kim WH, Devereaux PJ

出典‎: JAMA Surg 2025;160(3):267-74.

インデックス‎: PubMed 39813061

DOI‎: 10.1001/jamasurg.2024.6048

https://pubmed.ncbi.nlm.nih.gov/39813061/ (新しいタブで開く)

Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (新しいタブで開く)

Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, Messroghli L, Zacharowski K, Choorapoikayil S, Meybohm P

出典‎: JAMA Surg 2021;156(6):e210884.

インデックス‎: PubMed 33851983

DOI‎: 10.1001/jamasurg.2021.0884

https://www.ncbi.nlm.nih.gov/pubmed/33851983 (新しいタブで開く)

遺伝子組換え活性型血液凝固第Ⅶ因子製剤(rFVIIa)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (新しいタブで開く)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

出典‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

インデックス‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (新しいタブで開く)

濃縮凝固因子製剤

Fibrinogen replacement therapy: a critical review of the literature. (新しいタブで開く)

Franchini M, Lippi G.

出典‎: Blood Transfus 2012;10(1):23-7.

インデックス‎: PubMed 22153684

DOI‎: 10.2450/2011.0015-11

https://www.ncbi.nlm.nih.gov/pubmed/22153684 (新しいタブで開く)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (新しいタブで開く)

Levy JH, Welsby I, Goodnough LT.

出典‎: Transfusion 2014;54(5):1389-405.

インデックス‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (新しいタブで開く)

外科的出血か凝固異常による出血かを同定するための血液粘弾性試験

Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (新しいタブで開く)

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P.

出典‎: Eur J Anaesthesiol 2013;30(6):270-382.

インデックス‎: PubMed 23656742

DOI‎: 10.1097/EJA.0b013e32835f4d5b

https://www.ncbi.nlm.nih.gov/pubmed/23656742 (新しいタブで開く)